Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ALDX

Aldeyra Therapeutics (ALDX) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $0.92 -3.4% on the day -83.8% over 12 months 52-week range $0.92 – $5.67

Share price and insider trades

ALDX closeInsider buyInsider sale
0246NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $7,100 on 2026-03-18 · Michael AlfieriBought $98,000 on 2026-03-19 · Richard DouglasBought $417,500 on 2026-06-03 · Todd C Brady
Bought, 12 months$516K
Sold, 12 months$0
Insiders buying2
Insiders selling0

Aldeyra Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $516K and 0 sold $0 of ALDX stock on the open market.

ALDX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $105K bought (2 trades)$105KQ1 2026Q2 2026: $418K bought (1 trades)$418KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$418K1—0
Q1 2026$105K2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day4.1×Last 5 sessions
Insiders' paper profit−$225KOn all tracked purchases -43.0%

Summary

Over the past 12 months, 2 Aldeyra Therapeutics, Inc. insiders reported open-market purchases totaling $516K, while 0 insiders reported sales totaling $0.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jun 5SEC Todd C BradyCEO, President Buy 250,0001,721,298 held (+17%) $1.67 $418K -45.1% —
Mar 20SEC Richard DouglasDirector Buy 70,000195,000 held (+56%) $1.40 $98K -34.6% —
Mar 19SEC Michael AlfieriPrincipal Financial Officer Buy 5,0007,500 held (+200%) $1.42 $7K -35.5% —

Insiders at Aldeyra Therapeutics, Inc.

InsiderBoughtSoldLast filingScore
Todd C BradyCEO, President $418K — Jun 5, 2026 —
Richard DouglasDirector $98K — Mar 20, 2026 —
Michael AlfieriPrincipal Financial Officer $7K — Mar 19, 2026 —

ALDX stock: common questions

Are Aldeyra Therapeutics, Inc. insiders buying ALDX stock?

In the past 12 months, 2 insiders reported open-market purchases of ALDX worth $516K. The latest was CEO, President Todd C Brady bought $418K of ALDX at $1.67 — first open-market purchase in our records.

Are Aldeyra Therapeutics, Inc. insiders selling ALDX stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ALDX's 52-week range?

Over the past year ALDX has traded between $0.92 and $5.67. It last closed at $0.92 on Oct 9, 2026.